CMS pitches expanded coverage of PET scans for Alzheimer’s disease
(By Rylee Wilson for Becker’s Hospital Review) CMS is proposing broader coverage of PET scans for patients with Alzheimer’s disease,
Read More(By Rylee Wilson for Becker’s Hospital Review) CMS is proposing broader coverage of PET scans for patients with Alzheimer’s disease,
Read More(By Rylee Wilson for Becker’s Hospital Review) Medicare Advantage overpayments may be higher than the the Medicare Payment and Advisory
Read MoreThe FDA approved the drug Leqembi, and Medicare will cover the new expensive new drug that promises the slowing the
Read More(By Chris Lee for The Kaiser Family Foundation published July 12, 2023) A new KFF analysis finds that the 10
Read More(By Rylee Wilson for Becker’s Hospital Review) Total risk adjustment payments in individual and small group insurance plans increased in
Read More(By Rylee Wilson for Becker’s Hospital Review) Leqembi, the newly-approved drug that can slow the progression of Alzhemier’s disease, will
Read More(Source – www.cms.gov/newsroom) Broader Medicare coverage is now available for Biogen and Eisai’s Leqembi (the brand name for lecanemab) following
Read More(By Jakob Emerson for Becker’s Hospital Review) The Medicare Advantage star rating system and its quality bonus payment program is
Read More(Source – www.cms.gov/newsroom) For the first time in history, Medicare has the ability to directly negotiate the prices of covered
Read More(By Jakob Emerson for Becker’s Hospital Review) There are major changes afoot for Medicare Advantage plans and when they are
Read More